Literature DB >> 17948933

Genetic factors associated with the development of inflammatory bowel disease.

Jesus-K Yamamoto-Furusho1.   

Abstract

Crohn's disease (CD) and ulcerative colitis (UC) are complex polygenic disorders, characterized by several genes together with environmental factors contributing to the development of inflammatory bowel disease (IBD). Recent advances in research on genetic susceptibility have allowed the identification of diverse genes at different levels: (1) Innate immunity; (2) Antigen presentation molecules; (3) Epithelial integrity; (4) Drug transporter; (5) Cell adhesion. The application of genetic testing into clinical practice is close and all genetic markers may have several clinical implications: prediction of disease phenotype, molecular classification, prevention of complications, and prognosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17948933      PMCID: PMC4172738          DOI: 10.3748/wjg.v13.i42.5594

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  31 in total

1.  Association between K469E allele of intercellular adhesion molecule 1 gene and inflammatory bowel disease in a Japanese population.

Authors:  J Matsuzawa; K Sugimura; Y Matsuda; M Takazoe; K Ishizuka; T Mochizuki; S S Seki; O Yoneyama; H Bannnai; K Suzuki; T Honma; H Asakura
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

Review 2.  The genetics of inflammatory bowel disease.

Authors:  Denise K Bonen; Judy H Cho
Journal:  Gastroenterology       Date:  2003-02       Impact factor: 22.682

3.  Association analysis of SLC22A4, SLC22A5 and DLG5 in Japanese patients with Crohn disease.

Authors:  Keiko Yamazaki; Masakazu Takazoe; Torao Tanaka; Toshiki Ichimori; Susumu Saito; Aritoshi Iida; Yoshihiro Onouchi; Akira Hata; Yusuke Nakamura
Journal:  J Hum Genet       Date:  2004-10-19       Impact factor: 3.172

4.  Toll-like receptor-1, -2, and -6 polymorphisms influence disease extension in inflammatory bowel diseases.

Authors:  Marie Pierik; Sofie Joossens; Kristel Van Steen; Nele Van Schuerbeek; Robert Vlietinck; Paul Rutgeerts; Severine Vermeire
Journal:  Inflamm Bowel Dis       Date:  2006-01       Impact factor: 5.325

5.  Clustering of increased small intestinal permeability in families with Crohn's disease.

Authors:  M Peeters; B Geypens; D Claus; H Nevens; Y Ghoos; G Verbeke; F Baert; S Vermeire; R Vlietinck; P Rutgeerts
Journal:  Gastroenterology       Date:  1997-09       Impact factor: 22.682

6.  Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease.

Authors:  Dermot P B McGovern; Pirro Hysi; Tariq Ahmad; David A van Heel; Miriam F Moffatt; Alisoun Carey; William O C Cookson; Derek P Jewell
Journal:  Hum Mol Genet       Date:  2005-03-24       Impact factor: 6.150

7.  Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn's disease.

Authors:  H-P Török; J Glas; L Tonenchi; P Lohse; B Müller-Myhsok; O Limbersky; C Neugebauer; F Schnitzler; J Seiderer; C Tillack; S Brand; G Brünnler; P Jagiello; J T Epplen; T Griga; W Klein; U Schiemann; M Folwaczny; T Ochsenkühn; C Folwaczny
Journal:  Gut       Date:  2005-06-14       Impact factor: 23.059

Review 8.  Review article: genetic susceptibility and application of genetic testing in clinical management of inflammatory bowel disease.

Authors:  S Vermeire
Journal:  Aliment Pharmacol Ther       Date:  2006-10       Impact factor: 8.171

9.  Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease.

Authors:  Naohiro Inohara; Yasunori Ogura; Ana Fontalba; Olga Gutierrez; Fernando Pons; Javier Crespo; Koichi Fukase; Seiichi Inamura; Shoichi Kusumoto; Masahito Hashimoto; Simon J Foster; Anthony P Moran; Jose L Fernandez-Luna; Gabriel Nuñez
Journal:  J Biol Chem       Date:  2003-01-04       Impact factor: 5.157

10.  Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection.

Authors:  Stephen E Girardin; Ivo G Boneca; Jérôme Viala; Mathias Chamaillard; Agnès Labigne; Gilles Thomas; Dana J Philpott; Philippe J Sansonetti
Journal:  J Biol Chem       Date:  2003-01-13       Impact factor: 5.157

View more
  8 in total

1.  Moxibustion combined with acupuncture increases tight junction protein expression in Crohn's disease patients.

Authors:  Hai-Xia Shang; An-Qi Wang; Chun-Hui Bao; Huan-Gan Wu; Wei-Feng Chen; Lu-Yi Wu; Rong Ji; Ji-Meng Zhao; Yin Shi
Journal:  World J Gastroenterol       Date:  2015-04-28       Impact factor: 5.742

Review 2.  Pulmonary involvement and allergic disorders in inflammatory bowel disease.

Authors:  Nikolaos E Tzanakis; Ioanna G Tsiligianni; Nikolaos M Siafakas
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

3.  Immunoregulatory actions of epithelial cell PPAR gamma at the colonic mucosa of mice with experimental inflammatory bowel disease.

Authors:  Saroj K Mohapatra; Amir J Guri; Montse Climent; Cristina Vives; Adria Carbo; William T Horne; Raquel Hontecillas; Josep Bassaganya-Riera
Journal:  PLoS One       Date:  2010-04-20       Impact factor: 3.240

Review 4.  Rheumatic manifestations of inflammatory bowel disease.

Authors:  Tatiana Sofía Rodríguez-Reyna; Cynthia Martínez-Reyes; Jesús Kazúo Yamamoto-Furusho
Journal:  World J Gastroenterol       Date:  2009-11-28       Impact factor: 5.742

5.  Investigation of sesamol on myeloperoxidase and colon morphology in acetic acid-induced inflammatory bowel disorder in albino rats.

Authors:  Phani Krishna Kondamudi; Hemalatha Kovelamudi; Geetha Mathew; Pawan G Nayak; Mallikarjuna C Rao; Rekha R Shenoy
Journal:  ScientificWorldJournal       Date:  2014-01-30

6.  Evaluation of diet pattern related to the symptoms of mexican patients with Ulcerative Colitis (UC): through the validity of a questionnaire.

Authors:  Nallely Bueno-Hernández; Martha Núñez-Aldana; Ilse Ascaño-Gutierrez; Jesús K Yamamoto-Furusho
Journal:  Nutr J       Date:  2015-03-14       Impact factor: 3.271

7.  Pulmonary manifestations of inflammatory bowel disease.

Authors:  Sebastian Majewski; Wojciech Piotrowski
Journal:  Arch Med Sci       Date:  2015-12-11       Impact factor: 3.318

8.  Curcumin half analog modulates interleukin-6 and tumor necrosis factor-alpha in inflammatory bowel disease.

Authors:  Phani Krishna Kondamudi; Hemalatha Kovelamudi; Pawan G Nayak; Mallikarjuna Chamallamudi Rao; Rekha Raghuveer Shenoy
Journal:  Pharmacogn Mag       Date:  2015-10       Impact factor: 1.085

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.